Pharmaceuticals

Novartis teams up with Rani Therapeutics to create robotic pill

Novartis teams up with Rani Therapeutics to create robotic pill

Swiss pharmaceuticals giant Novartis has teamed up with the U. S.-based Rani Therapeutics to create a robotic pill for complex biotech drugs. The robotic capsule will contain tiny needles made of sugar that would deliver the drug after pushing into the wall of the intestine.

The pill so far has to be administered into patients through injections.

emplacements: 
nouvelles generales: 
entreprises: 
economie: 

Medical firms offering discount on Hepatitis C medication

Medical firms offering discount on Hepatitis C medication

Medical experts have said producers are offering substantial discounts on the only hepatitis C drug makers in the market as part of a prolonged price war in the industry.

nouvelles generales: 
emplacements: 
economie: 

Pfizer reports positive results for ROS1 positive lung cancer patients with Xalkori

Pfizer reports positive results for ROS1 positive lung cancer patients with Xalk

Medical researchers have announced positive results for Pfizer' Xalkori for non-small cell lung cancer patients. The clinical trial involving 50 patients with non-small cell lung cancer has reported decline in tumor for 36
(or 72 percent) of the patients and tumor growth halt in 9 patients (18 percent).

Study leader Dr. Alice Shaw presented the results at European Society for Medical Oncology (ESMO) in Madrid, Spain on Sunday.

personnes: 
entreprises: 
economie: 

CVS Pharmacy stops selling Tobacco for Public Health

CVS Pharmacy stops selling Tobacco for Public Health

CVS Pharmacy, the second largest pharmacy chain in the United States after Walgreens, has stopped selling tobacco for public health. The pharmacy chain has executed the change nearly a month earlier than considered.

entreprises: 
emplacements: 

Novartis’ New Drug Effective in Treating Heart Ailments

Novartis’ New Drug Effective in Treating Heart Ailments

A new heart drug by Swiss company Novartis has shown amazing efficacy in treating people with heart and cardiovascular diseases.

nouvelles generales: 
entreprises: 
economie: 

New Sleeping Pill Belsomra approved by FDA

New Sleeping Pill Belsomra approved by FDA

Merck & Co, one of the largest American pharmaceutical companies, has won approval from Food and Drug Administration (FDA) for its new sleeping pill. The pill has been specifically formulated to help people suffering from insomnia. The pill has been approved in four different doses for various degrees of insomnia i. e. 5, 10, 15 and 20mg.

Its availability is expected in late 2014 or early 2015, once the Drug Enforcement Administration makes its final decision on the scheduling of the drug.

nouvelles generales: 
entreprises: 
economie: 

AstraZeneca Joins Hands with Roche, Qiagen for New blood-based drug to Benefit Lung Cancer Patients

AstraZeneca Joins Hands with Roche, Qiagen for New blood-based drug to Benefit L

AstraZeneca has signed up an agreement with Roche and Qiagen to develop liquid biopsy-based smart diagnostics for detection of cancer and the effectiveness of medicines among the patients. The companies will develop two separate diagnostic tests, both using simple blood samples to check the efficacy of cancer drugs from AstraZeneca.

Peer M. Schatz, Chief Executive Officer of QIAGEN, expressed that the collaboration with AstraZeneca will improve the treatment options for lung cancer patients.

emplacements: 
personnes: 

GSK Applying for Regulatory Approval of World’s First Malaria Vaccine

GSK Applying for Regulatory Approval of World’s First Malaria Vaccine

GlaxoSmithKline (GSK. L) has developed the world's first vaccine against malaria. The vaccine will be used for children in Africa. The British drugmaker announced that it is applying for the regulatory approval for the shot, called RTS, S.

The drug will be used outside the European Union, but it will be assessed by the European Medicines Agency (EMA) along with the World Health Organisation (WHO).

emplacements: 
personnes: 
entreprises: 
economie: 

Pages